Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.41 |
| ▸ | TTR | P02766 | 1/20 | 0.41 |
| ▸ | ALB | P02768 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31294509 | 1.00 | TSHR (0.46) | TSHRCASP1ALDH1A1CYP2A6CA12 | |
| SCHEMBL26936685 | 0.84 | MMP3 (0.55) | TSHRCASP1ALDH1A1CYP2A6CA12 | |
| SCHEMBL2331670 | 0.82 | AR (0.50) | ALDH1A1CYP2A6CA12CA2CA3 | |
| SCHEMBL29449995 | 0.78 | CA12 (0.52) | TSHRALDH1A1CYP2A6CA12CA2 | |
| SCHEMBL217250 | 0.78 | CA12 (0.52) | TSHRALDH1A1CYP2A6CA12CA2 | |
| SCHEMBL1436903 | 0.78 | CYP2A6 (0.52) | ALDH1A1CYP2A6CA12CA2CA3 | |
| SCHEMBL29814587 | 0.78 | CYP2A6 (0.52) | ALDH1A1CYP2A6CA12CA2CA3 | |
| SCHEMBL2807586 | 0.77 | TSHR (0.46) | TSHRCASP1ALDH1A1CA12CA2 | |
| SCHEMBL23271632 | 0.76 | CA12 (0.50) | TSHRALDH1A1CA12CA2CA3 | |
| SCHEMBL34461940 | 0.76 | CA12 (0.50) | TSHRALDH1A1CA12CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119775566-B | Cyano resin containing cage-shaped silsesquioxane structure and preparation method thereof | 西华大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119775566-A | Cyano resin containing cage-shaped silsesquioxane structure and preparation method thereof | 西华大学 | 2025-04-08 | — | — | CN | claimed |
| CN-119355157-A | Method for determining impurity content of 4-cyano-2-methoxybenzaldehyde serving as non-nelidanone starting material | 江苏联环药业股份有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-113311605-B | Decorative film, shell assembly and electronic equipment | OPPO广东移动通信有限公司 | 2022-11-29 | — | — | CN | claimed |
| CN-113311605-A | Decorative film, shell assembly and electronic equipment | OPPO广东移动通信有限公司 | 2021-08-27 | — | — | CN | claimed |
| CN-122094943-A | Novel 1,2, 4-oxadiazoles as fungicides | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4674843-A1 | TETRAZINE ANALOGUES FOR THERANOSTIC APPLICATION | University of Copenhagen (DK) | 2026-01-07 | — | — | EP | disclosed |
| US-20250388571-A1 | AMP-ACTIVATED PROTEIN KINASE MODULATOR COMPOUNDS AND USES THEREOF | BIOLEXIS THERAPEUTICS INC (US) | 2025-12-25 | — | — | US | disclosed |
| CN-119775566-B | Cyano resin containing cage-shaped silsesquioxane structure and preparation method thereof | 西华大学 | 2025-05-13 | — | — | CN | disclosed |
| CN-119775566-A | Cyano resin containing cage-shaped silsesquioxane structure and preparation method thereof | 西华大学 | 2025-04-08 | — | — | CN | disclosed |
| WO-2025052333-A1 | NOVEL 1,2,4-OXADIAZOLES COMPOUNDS AS FUNGICIDE | PI INDUSTRIES LTD. (IN) | 2025-03-13 | — | — | WO | disclosed |
| CN-119546605-A | Protein degradation agent | 苏州开拓药业股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-1154114-A | New thrombin inhibitors, their preparation and use | BASF AG (DE) | 1997-07-09 | — | — | CN | disclosed |
| WO-1996025426-A9 | NOVEL DIPEPTIDE AMIDINES AS THROMBIN INHIBITORS | — | 1997-06-12 | — | — | WO | disclosed |
| EP-0773955-A1 | NEW THROMBIN INHIBITORS, THEIR PREPARATION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 1997-05-21 | — | — | EP | disclosed |
| WO-1996025426-A1 | NOVEL DIPEPTIDE AMIDINES AS THROMBIN INHIBITORS | BASF AKTIENGESELLSCHAFT (DE) | 1996-08-22 | — | — | WO | disclosed |
| WO-1996024609-A1 | THROMBIN INHIBITORS | BASF AKTIENGESELLSCHAFT (DE) | 1996-08-15 | — | — | WO | disclosed |
| WO-1995035309-A1 | NEW THROMBIN INHIBITORS, THEIR PREPARATION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 1995-12-28 | — | — | WO | disclosed |
| US-5059610-A | QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-10-22 | — | — | US | disclosed |
| US-4920132-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388571-A1 | AMP-ACTIVATED PROTEIN KINASE MODULATOR COMPOUNDS AND USES THEREOF | PRKAB2, PRKAB1, PRKAR2B | TSHR 919/4885CASP1 3534/4885ALDH1A1 4339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.